Clinical Trials Browser

Phase 1 × pazopanib × 90 days × Clear all

NCT01642017 2026-04-14

VOTRAGE

Phase 1 Terminated

Neoplasm Metastasis

NCT01552356 2026-04-13

Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors

Phase 1 Active not recruiting

Solid Neoplasm